<p>Pemetrexed is indicated for:</p>

<ul>
	<li>Initial treatment of patients with locally advanced or metastatic, non-squamous,&nbsp;non-small cell lung cancer&nbsp;(NSCLC) in combination with&nbsp;cisplatin.</li>
	<li>Maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line&nbsp;chemotherapy, as a single agent.</li>
	<li>Treatment of patients with&nbsp;recurrent, metastatic non-squamous, NSCLC after prior chemotherapy, as a single agent.</li>
</ul>